Animal experiments were carried out in accordance with the European Communities Council Directive of 22 September 2010 (2010/63/EU) and were reviewed and permitted by Swiss authorities.
1. Setting up Organotypic Entorhino-hippocampal Slice Cultures
2. In Vitro Hypoxia and Oxygen-glucose Deprivation with Reperfusion
3. Pharmacological Treatments of Entorhino-hippocampal Organotypic Slice Cultures
4. Fixation and Immunostaining of Entorhino-hippocampal Organotypic Slice Cultures
5. Determination of Regional Vessel Density in the Cultures
Oxygen glucose deprivation and hypoxia induce neuronal death and blood vessel reduction specifically in the hippocampal CA1 region.
OGD or oxygen-deprivation alone for 15 min induced a strong induction of cell death as seen by propidium iodide staining specifically in the CA1 area of the hippocampus (Figure 3) similar as described previously7. With markers to visualize the network of blood vessels, it was found that blood vessel density and organization appeared similar to the control after OGD challenge in most parts of the culture with the exception of the CA1 region. There the blood vessel density was decreased and the blood vessel network was partially disrupted (Figure 3, E and F). These changes were seen only in the area where the propidium iodide staining was increased.
The time course of the vascular changes parallels that of neuronal degeneration.
We have studied the time course of both neuronal degeneration and blood vessel loss in CA1 using time points at 3 hr, 24 hr and 48 hr after oxygen deprivation (hypoxia). At 3 hr post hypoxia, there was no propidium iodide staining visible and there were no changes present in the blood vessel architecture indicating that at this time no changes were visible yet (Figure 4, A and B). At 24 hr post hypoxia there was appearance of propidium iodide staining indicating the progression of cell death in CA1. At this time point the network of blood vessels was already disturbed and blood vessels were lost in the CA1 region (Figure 4, C and D). Both, propidium iodide staining and blood vessel loss became more pronounced at 48 hr post hypoxia (Figure 4, E and F).
Both neuronal death and blood vessel loss are prevented by blocking excitation after OGD or hypoxia.
When we combined OGD with pharmacological treatments that prevented excess glutamate release, it was possible to rescue neurons from OGD-induced cell death. Treatment with TTX (which inhibits action potential generation resulting in the silencing of afferent terminals) or treatment with CNQX (which inhibits AMPA-type glutamate receptors) rescued CA1 pyramidal cells from neuronal death (Figure 5, D and F). These results indicate that neuronal death after OGD is mediated by excitotoxic action of glutamate. After these treatments, not only neuronal cell death was prevented, but also the vessel integrity was preserved and the loss of blood vessels in CA1 was prevented (Figure 5, C and E).
AMPA treatment induces widespread excitotoxic neuronal death in the hippocampus but vessel loss is restricted to CA1.
OGD as used in this study induces neuronal death specifically in CA1. In contrast, treatment with 100 µM AMPA for 30 min induced a widespread neuronal loss in the entire cornu ammonis of the hippocampus (CA1 and CA3) and the subiculum but not in the dentate gyrus (Figure 6C). Interestingly, blood vessel loss was confined to the CA1 region, despite a similar neuronal loss in CA3 there was no blood vessel loss in this region (Figure 6D). In the dentate gyrus there was neither neuronal death nor blood vessel loss. The quantification of vessel density confirms that blood vessels are lost in CA1, but not in the other regions of the culture Figure 6E.
Figure 1. Schedule of OGD exposure and reperfusion. After 5 days in vitro cultures are subjected to OGD, hypoxia or AMPA treatment. Cultures are fixed after a survival time of 3 hr, 24 hr and 48 hr.
Figure 2. Quantification of blood vessel density in different regions of the entorhino-hippocampal slice cultures. Three 6 x 6 grids (here shown as squares) are overlaid in the CA1, CA3, DG, and EC region. The blood vessels crossing the internal lines of the grid were counted for each square.
Figure 3. Hypoxia treatment induces neuronal death and blood vessel loss in CA1. (A, C, E) control cultures, (B, D, F) cultures subjected to hypoxia treatment followed by 48 hr of normoxia. Laminin immunostaining at low magnification in green (A, B), PI staining at higher magnification in red (C. D), merged images for laminin and PI staining in (E) and (F). Scale bars in (B for A, B) and (F for C, D, E, F) = 100 µm. Please click here to view a larger version of this figure.
Figure 4. Time course of vascular changes and neuronal degeneration after oxygen deprivation (hypoxia). PI staining in red shown in (A, C, E), merged images for PI staining and laminin (green) shown in (B, D, F). At 3 hr post hypoxia treatment, there is no PI staining visible and no vascular changes are evident (A, B). After 24 hr PI staining emerges and blood vessel loss is also evident (C, D). Both PI staining and blood vessel loss become more evident after 48 hr (E, F). Scale bar in (F) = 100 µm. Please click here to view a larger version of this figure.
Figure 5. Neuronal death and blood vessel loss are prevented by blockers of neuronal excitation. Application of either TTX (C, D) or CNQX (E, F) prevented both neuronal loss as seen with PI staining (B, D, F) and blood vessel loss revealed by laminin staining (A, C, E). OGD alone induces both neuronal loss and loss of blood vessels in CA1 (A, B). Scale bar in (F) = 100 µm. Please click here to view a larger version of this figure.
Figure 6. Neuronal death and blood vessel loss after AMPA treatment. Treatment with 100 µM AMPA for 30 min induced widespread neuronal loss in most areas of the hippocampus (C), but the loss of blood vessels remained restricted to area CA1 (D). Scale bar in (D) = 100 µm. The quantification of blood vessels confirms the selective loss in the CA1 area (E). Columns show the mean number of vessel crossings, error bars showing the SEM. Significant differences are indicated with ** for p<0.01. Results were derived from three independent experiments with three analyzed cultures each (n=9) for every region. Please click here to view a larger version of this figure.
Time | Action |
DIV 4 | Prepare OGD or hypoxia medium |
DIV 4 | Perfuse the OGD or hypoxia medium with N2 for 1 hr in a hypoxia chamber and then seal and keep O/N in an incubator at 37 °C |
DIV 4 | Switch the cultures to Neurobasal serum free medium + glucose from incubation medium, allow them to rest O/N or 1 day |
DIV 5 | Perfuse the OGD medium again with N2 for 30 min |
DIV 5 | Add 2 µl of a 1 mg/ml propidium iodide (PI) solution per well (for a final concentration of 2 µg/ml) to the slices for 30 min and select only healthy slices for experimentation as indicated by low numbers of PI positive cells |
DIV 5 | Suck off the regular medium and add OGD medium to the wells. Ensure that all fluids that remain on the sides of the insert are aspirated away when the cultures are switched from regular medium to OGD/hypoxia medium and back. Transfer the plate to the hypoxia chamber |
DIV 5 | Perfuse with N2 for 15 min in the hypoxia chamber |
DIV 5 | Remove plate from chamber. Switch back to Neurobasal medium and place back in humidified incubator with 5% CO2 |
DIV 5 | Add PI and fix 3 hr after OGD/hypoxia for 3 hr interval |
DIV 6 | Add PI and fix 24 hr after OGD/hypoxia for 24 hr interval |
DIV 7 | Add PI and fix 48 hr after OGD/hypoxia for 48 hr interval |
Table 1. Detailed time sequence of steps for OGD/hypoxia treatment.
Name of Material/ Equipment | Company | Catalog Number | Comments/Description |
Minimum Essential Medium MEM | Gibco | 11012-044 | |
Glutamax | Gibco | 35050-061 | stabilized form of L-glutamine |
Millicell cell culture inserts | Millipore | PICM03050 | |
Basal medium Eagle | Gibco | 41010-026 | |
Horse serum | Gibco | 26050-088 | |
Neurobasal medium | Gibco | 21103-049 | |
B27 supplement | Gibco | 17504-044 | |
Anaerobic strips | Sigma-Aldrich | 59886 | |
Propidium iodide solution | Sigma-Aldrich | P4864 | |
AMPA | R&D systems | 0169-10 | |
CNQX | R&D systems | 0190/10 | |
TTX | R&D systems | 1078/1 | |
polyclonal anti-laminin | Sigma-Aldrich | L9393 | |
anti-MAP2 | Abcam | ab11267 | |
Alexa anti mouse 350 | Molecular Probes | A11045 | |
Alexa anti mouse 488 | Molecular Probes | A11001 | |
Alexa anti rabbit 350 | Molecular Probes | A11046 | |
Alexa anti rabbit 488 | Molecular Probes | A11008 | |
Statistics software | GraphPad Software | GraphPad Prism | |
McIlwain tissue chopper | Ted Pella | 10180 | |
Hypoxia chamber | Billups-Rothenberg | MIC-101 |
Ischemic brain injury is among the most common and devastating conditions compromising proper brain function and often leads to persisting functional deficits in the affected patients. Despite intensive research efforts, there is still no effective treatment option available that reduces neuronal injury and protects neurons in the ischemic areas from delayed secondary death. Research in this area typically involves the use of elaborate and problematic animal models. Entorhino-hippocampal organotypic slice cultures challenged with oxygen and glucose deprivation (OGD) are established in vitro models which mimic cerebral ischemia. The novel aspect of this study is that changes of the brain blood vessels are studied in addition to neuronal changes and the reaction of both the neuronal compartment and the vascular compartment can be compared and correlated. The methods presented in this protocol substantially broaden the potential applications of the organotypic slice culture approach. The induction of OGD or hypoxia alone can be applied by rather simple means in organotypic slice cultures and leads to reliable and reproducible damage in the neural tissue. This is in stark contrast to the complicated and problematic animal experiments inducing stroke and ischemia in vivo. By broadening the analysis to include the study of the reaction of the vasculature could provide new ways on how to preserve and restore brain functions. The slice culture approach presented here might develop into an attractive and important tool for the study of ischemic brain injury and might be useful for testing potential therapeutic measures aimed at neuroprotection.
Ischemic brain injury is among the most common and devastating conditions compromising proper brain function and often leads to persisting functional deficits in the affected patients. Despite intensive research efforts, there is still no effective treatment option available that reduces neuronal injury and protects neurons in the ischemic areas from delayed secondary death. Research in this area typically involves the use of elaborate and problematic animal models. Entorhino-hippocampal organotypic slice cultures challenged with oxygen and glucose deprivation (OGD) are established in vitro models which mimic cerebral ischemia. The novel aspect of this study is that changes of the brain blood vessels are studied in addition to neuronal changes and the reaction of both the neuronal compartment and the vascular compartment can be compared and correlated. The methods presented in this protocol substantially broaden the potential applications of the organotypic slice culture approach. The induction of OGD or hypoxia alone can be applied by rather simple means in organotypic slice cultures and leads to reliable and reproducible damage in the neural tissue. This is in stark contrast to the complicated and problematic animal experiments inducing stroke and ischemia in vivo. By broadening the analysis to include the study of the reaction of the vasculature could provide new ways on how to preserve and restore brain functions. The slice culture approach presented here might develop into an attractive and important tool for the study of ischemic brain injury and might be useful for testing potential therapeutic measures aimed at neuroprotection.
Ischemic brain injury is among the most common and devastating conditions compromising proper brain function and often leads to persisting functional deficits in the affected patients. Despite intensive research efforts, there is still no effective treatment option available that reduces neuronal injury and protects neurons in the ischemic areas from delayed secondary death. Research in this area typically involves the use of elaborate and problematic animal models. Entorhino-hippocampal organotypic slice cultures challenged with oxygen and glucose deprivation (OGD) are established in vitro models which mimic cerebral ischemia. The novel aspect of this study is that changes of the brain blood vessels are studied in addition to neuronal changes and the reaction of both the neuronal compartment and the vascular compartment can be compared and correlated. The methods presented in this protocol substantially broaden the potential applications of the organotypic slice culture approach. The induction of OGD or hypoxia alone can be applied by rather simple means in organotypic slice cultures and leads to reliable and reproducible damage in the neural tissue. This is in stark contrast to the complicated and problematic animal experiments inducing stroke and ischemia in vivo. By broadening the analysis to include the study of the reaction of the vasculature could provide new ways on how to preserve and restore brain functions. The slice culture approach presented here might develop into an attractive and important tool for the study of ischemic brain injury and might be useful for testing potential therapeutic measures aimed at neuroprotection.